2. Academic Validation
  3. Alpha-ethyltryptamines as dual dopamine-serotonin releasers

Alpha-ethyltryptamines as dual dopamine-serotonin releasers

  • Bioorg Med Chem Lett. 2014 Oct 1;24(19):4754-4758. doi: 10.1016/j.bmcl.2014.07.062.
Bruce E Blough 1,  Antonio Landavazo 2,  John S Partilla 3,  Ann M Decker 2,  Kevin M Page 2,  Michael H Baumann 3,  Richard B Rothman 3
Affiliations

Affiliations

  • 1 Center for Drug Discovery, Research Triangle Institute, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA. Electronic address: beb@rti.org.
  • 2 Center for Drug Discovery, Research Triangle Institute, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA.
  • 3 Medicinal Chemistry Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA.
PMID: 25193229 DOI: 10.1016/j.bmcl.2014.07.062
Abstract

The dopamine (DA), serotonin (5-HT), and norepinephrine (NE) transporter releasing activity and serotonin-2A (5-HT2A) receptor agonist activity of a series of substituted tryptamines are reported. Three compounds, 7b, (+)-7d and 7f, were found to be potent dual DA/5-HT releasers and were >10-fold less potent as NE releasers. Additionally, these compounds had different activity profiles at the 5-HT2A receptor. The unique combination of dual DA/5-HT releasing activity and 5-HT2A receptor activity suggests that these compounds could represent a new class of neurotransmitter releasers with therapeutic potential.

Keywords

5-HT 2A receptor; 5-HT releasers; DA releasers; Tryptamines.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z